Benzinga
Benzinga
Benzinga
jeudi, septembre 24

HCA Healthcare Inc

HCANYSE
Trade with Public
Trade with Public
$423.48
-13.00-2.98%
À la clôture: Sep 24, 5:00 PM EST
$423.00
-0.48-0.11%
Après les heures: 4:07 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatDividendesComparerRapport sur les stocks

HCA Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for HCA Healthcare (HCA).

Price Target Range — 8 Quarters

Analyst Consensus — 22 Analysts

15Buy
6Hold
1Sell
Consensus RatingBuy# Analysts22Avg. Consensus PT$473Upside to Avg. PT+11.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Sep 23, 2026BMO CapitalSean DodgeInitiateOutperform$495
Sep 18, 2026Leerink PartnersWhit MayoMaintainedOutperform$492
More with Benzinga EdgeGet Access

Analyst Ratings News

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Avi Kapoor

PRO
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform rating and announces Price Target of $495.
Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $490 to $425.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $369 to $381.
Benzinga Newsdesk

PRO
Goldman Sachs Maintains Buy on HCA Healthcare, Lowers Price Target to $485

Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $558 to $485.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved